Perspective Therapeutics, Inc. CATX
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -22.62% | -30.48% | -30.07% | -65.87% | -60.89% |
| Total Depreciation and Amortization | 42.67% | 36.00% | 41.10% | 87.27% | 140.34% |
| Total Amortization of Deferred Charges | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Non-Cash Items | -39.75% | -40.19% | -41.60% | 82.84% | 92.44% |
| Change in Net Operating Assets | 243.73% | -246.73% | -94.71% | -122.84% | -104.86% |
| Cash from Operations | -43.68% | -71.93% | -350.88% | -12,031.18% | -357.06% |
| Capital Expenditure | 43.77% | 70.10% | 76.57% | 44.12% | -380.72% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 80.09% | 62.51% | 132.74% | -156.50% | -196.18% |
| Cash from Investing | 69.34% | 64.58% | 118.83% | -56.57% | -233.23% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -10.20% | -8.33% | -6.25% | -1.89% |
| Issuance of Common Stock | 1,429.14% | 24.13% | -96.42% | -96.42% | -96.27% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,386.83% | 23.80% | -96.44% | -96.32% | -96.16% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 108.79% | 109.77% | -159.34% | -195.87% | -199.84% |